2月11日 (日)
14:00 - 17:00
午後のショートコース
MOSCONE SOUTH CONVENTION CENTER | SAN FRANCISCO

SC1: 血中循環腫瘍細胞と血中循環腫瘍DNAの臨床応用に向けた展開

Dana W.Y. Tsui, Ph.D., Assistant Attending Geneticist; Member, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center

Emmanuel Antonarakis, M.D., Associate Professor, Urologic Oncology, Johns Hopkins University

Sonya Parpart-Li, Ph.D., Team Lead, Product Development, Personal Genome Diagnostics

SC2: 次世代シーケンシングに対応するアッセイの選択、検証、コンプライアンス

Maria E. Arcila, M.D., Pathologist and Director, Diagnostic Molecular Pathology Laboratory, Memorial Sloan Kettering Cancer Center (AMP Member)

Eric Duncavage, M.D., Assistant Professor, Pathology & Immunology, Washington University School of Medicine (AMP Hematopathology Subdivision Representative to the AMP 2018 Program Committee; Member)

Birgit Funke, Ph.D., FACMG, Vice President, Clinical Affairs, Veritas Genetics; Associate Professor of Pathology, Harvard Medical School (AMP Genetics Subdivision Chair and Representative to the AMP 2018 Board of Directors; Member)

SC3: シーケンシング入門

Ryan Kim, Ph.D., Director, Korean Bioinformatics Center (KOBIC), Korea Research Institute of Bioscience & Biotechnology (KRIBB)

SC4: がん免疫療法に対応するオミクス技術

James Robert White, Ph.D., Founder, Resphera Biosciences

Xing Wang, Ph.D., President, R&D, Array Bridge Inc

Lauren Ritterhouse, M.D., PH.D., Assistant Professor of Pathology, Genomic and Molecular Pathology Division The University of Chicago Medicine & Biological Sciences

SC5: 先進的な診断法の補償範囲と償還

Kurt Matthes, Vice President, RCM Reengineering and Service, Revenue Cycle Management, TELCOR, Inc.

Girish Putcha, M.D., Ph.D., Director of Laboratory Science, MolDx, Palmetto GBA

Additional Instructors to be Announced

SC6: 患者の血中循環腫瘍細胞検出のための革新的な画像処理技術

Stuart S. Martin, Ph.D., Professor of Physiology, Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine

SC7: 精密医療の概要

Jeanette McCarthy, MPH, Ph.D., Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors


2月11日 (日)
17:30 - 20:30
ディナーショートコース
MOSCONE SOUTH CONVENTION CENTER | SAN FRANCISCO

SC9: 臨床インフォマティクス:ビッグデータから導き出される分析結果

N. Sertac Kip, M.D., Ph.D., Director, Oncology, Mount Sinai Hospital (AMP Member)

Mark Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center (AMP Informatics Subdivision Representative to the AMP 2017 Clinical Practice Committee; Member)

SC10: 分子診断の分野における規制遵守

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.

Additional Instructors to be Announced

SC11: リキッドバイオプシー技術と応用

John Simmons, Ph.D., Director, Translational Science & Diagnostics, Personal Genome Diagnostics

Hatim Husain, M.D., Physician, Medical Oncology, University of California, San Diego

SC12: クラウド技術を利用してヒトのゲノムと臨床転帰データの大規模な統合を実現するための取り組み

R. Mark Adams, Ph.D., CIO, Celmatix, Inc.

Anna T. Fernandez, Ph.D., PMP, Senior Associate, Civil Health - Informatics, Booz Allen Hamilton

Andrew FigPope, Data Engineer, Celmatix, Inc.

Sam Globus, Ph.D., Director of Scientific Operations, Celmatix, Inc.

Michael Keller, Ph.D., Senior Associate, Civil Health, Booz Allen Hamilton

Christopher Matta, Systems Engineer, Confluent, Inc.

SC13: 科学研究と商業化の間の橋渡し:KOLの活用

Lawrence J. Worden, Principal, IVD Logix

Charles Mathews, Vice President, Boston Healthcare Associates

Peggy Robinson, Vice President, Angle PLC

SC14: チェックポイント免疫療法のためのバイオアッセイ開発

Mei Cong, Ph.D., Director, R&D Custom Assay Services, Promega

SC15: ポイントオブケア検査のためのマイクロ流体およびラボオンチップ装置:技術と商品化

Chris Myatt, Founder & CEO, MBio Diagnostics, Inc.

Additional Instructors to Be Announced


2月12日 (月)
8:00 - 11:00 AM
午前のショートコース
MOSCONE SOUTH CONVENTION CENTER | SAN FRANCISCO

SC17: 商業化に関する集中講座:分子診断の分野で成果をあげるための手引き

Harry Glorikian, MBA, Healthcare Consultant

Stan Skrzypczak, MBA, Vice President, Corporate Development and Reimbursement, Guardant Health, Inc.

Recommended Course Material: Commercializing Novel IVDs: A Comprehensive Manual for Success

Harry Glorikian, MBA, Healthcare Consultant; Author, Commercializing Novel IVD's Content

Based on the Commercialization Bootcamp Course and experience, the Commercializing Novel IVDs: A Comprehensive Manual for Success, greatly expands on the fundamental topics everyone in or around the IVD industry needs to know - from product ideation and design to regulation to planning for market entry and reimbursement. For companies just starting out, this book is like having your very own IVD reference manual at your fingertips, providing you with a comprehensive overview to help make the process as smooth as possible. For those of you already in the field, it's a guide that may help bring you up-to-date on the key trends impacting the industry, evolving regulatory issues, and changes that are impacting the way IVDs are marketed and sold. I have tried to present not just the big picture, but highlight the details that might be critical for success.

SC18: 診断プラットフォームとしての次世代シーケンシング

Karl V. Voelkerding, M.D., Professor of Pathology, University of Utah School of Medicine

Additional Instructors to be Announced

SC19: がん免疫の分野における前臨床研究のためのマウスモデル

Michael Brehm, Ph.D., Associate Professor, The Robert and Sandra Glass Term Chair in Diabetes, Diabetes Center of Excellence, Program in Molecular Medicine, University of Massachusetts Medical School

Rosemary J. Akhurst, Ph.D., Professor and Director, Preclinical Therapeutics Core, UCSF Helen Diller Family Comprehensive Cancer Center

SC20: 個別化医療と展開医療のベストプラクティス

Corey Bakalarski, Ph.D., Scientist, Genentech

Paul Fretter, Head of Computing Infrastructure for Science (CiS), NBI Partnership Ltd.
Ori Geva, Co-founder and CEO, Medial EarlySign

Stephen F. Kingsmore, M.D., D.Sc., President and CEO, Rady Children's Institute for Genomic Medicine

Gavin Stone, Vice President of Marketing, Edico Genome

Paul Trevithick, Director, Business Solutions, EPAM Systems


SC21: 感染性疾患診断のための次世代シーケンシング

Charles Chiu, M.D., Ph.D., Associate Professor of Laboratory Medicine and Medicine, Division of Infectious Diseases at University of California, San Francisco, Director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC), and Associate Director of the UCSF Clinical Microbiology Laboratory

SC22: がん免疫療法の創薬と開発に対応する細胞ベースのバイオマーカー

Nathan Standifer, Ph.D., Scientist II, Clinical Pharmacology and DMPK, MedImmune

Mark Edinger, Scientific Affairs Director, Flow Cytometry, Q2 Solutions

Iulian Pruteanu-Malinici, Ph.D., Biostatistics, Investigator II, Lab Head, Novartis Institutes for BioMedical Research (NIBR)

SC23: ヒトの染色体モザイク現象:着床前遺伝子スクリーニング検査、出生前診断、無侵襲的出生前検査

Brynn Levy, Professor, Pathology & Cell Biology at CUMC; Director, Clinical Cytogenetics Laboratory; Co-Director, Division of Personalized Genomic Medicine, College of Physicians and Surgeons, Columbia University Medical Center, and the New York Presbyterian Hospital


2月14日 (水)
18:00 - 21:00
ディナーショートコース
HILTON SAN FRANCISCO UNION SQUARE

SC25: 血中バイオマーカーの探索と特性化

Catherine Alix-Panabieres, Ph.D., Director, Laboratory of Rare Human Circulating Cells (LCCRH), Cellular and Tissular Biopathology of Cancers, University Medical Center of Montpellier

Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, University of Hamburg

SC26: マルチプレックスな単一細胞解析:手法の組み合わせ

Junyue Cao, Research Assistant, Jay Shendure Laboratory, Genomic Science, University of Washington

Ryan Mulqueen, Research Scientist, Brian J. O'Roak and Andrew Adey Laboratories, Molecular and Medical Genetics, Oregon Health & Science University

Kristof Torkenczy, Research Scientist, Andrew Adey Laboratory, Department of Molecular and Medical Genetics, Oregon Health & Science University

SC27: 創薬および標的治療薬開発のためのCRISPRを基盤とした遺伝子編集

Clifford Steer, M.D., Professor of Medicine and, Genetics, Cell Biology, and Development; Director, Molecular Gastroenterology Program, University of Minnesota Medical School

Arthur L. Shaffer III, Ph.D., Staff Scientist, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health

Daniel P. Dever, Ph.D., Instructor, Laboratory of Dr. Matthew Porteus, Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford University Medical Center

SC28: 多様体翻訳についての理解

Jeanette McCarthy, MPH, Ph.D., Adjunct Associate Professor, Duke University; Founder, Precision Medicine Advisors

* 不測の事態により、事前の予告なしにプログラムが変更される場合があります。


Choose your language
Traditional Chinese
Simplified Chinese
Korean
English



カタログダウンロード
カタログ(PDF)


メール配信サービス